UV strategy for controlled treatment of atherosclerosis

Irving Itzkan; Michael S. Feld

doi:10.1364/OAM.1991.TuL3

Optical Society of America Annual Meeting
Technical Digest Series (Optica Publishing Group, 1991),
paper TuL3
•https://doi.org/10.1364/OAM.1991.TuL3

UV strategy for controlled treatment of atherosclerosis

Irving Itzkan and Michael S. Feld

OSA Annual Meeting 1991

San Jose, California United States
3–8 November 1991
ISBN:

From the session
LEOS/OSA Joint Session: 1 (TuL)

Open Access

Get PDF
Email
Share
Get Citation
Copy Citation Text
I. Itzkan and M. S. Feld, "UV strategy for controlled treatment of atherosclerosis," in Optical Society of America Annual Meeting, Technical Digest Series (Optica Publishing Group, 1991), paper TuL3.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

We discuss the experimental results obtained on optical fiber breakdown and calcified tissue ablation which led us to choose a 355-nm, 400-ns laser as the ablation laser for the treatment of atherosclerosis.

PDF Article

More Like This

An angiosurgery system using a tripled Nd:YAG laser

Michael S. Feld, Irving Itzkan, and John R. Kramer
TuL2 OSA Annual Meeting (FIO) 1991

Laser-induced spectral diagnosis of atherosclerosis

R. Richards-Kortum, C. Kittrell, Michael S. Feld, and N. B. Ratliff
TUF2 Conference on Lasers and Electro-Optics (CLEO:S&I) 1986

Laser ablation and fiber-optic damage thresholds for laser angioplasty

Warren S. Grundfest, Frank Litvack, Tsvi Goldenberg, Lynn Doyle, Tom Pacala, James Laudenslager, and James Forrester
FE1 International Laser Science Conference (ILS) 1986

Previous Article Next Article